Luyan Pharma Co (SZSE:002788) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Change In Payables And Accrued Expense?

Luyan Pharma Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Luyan Pharma Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Luyan Pharma Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Luyan Pharma Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Luyan Pharma Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Luyan Pharma Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Change In Payables And Accrued Expense Chart

Luyan Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Luyan Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Luyan Pharma Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Luyan Pharma Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Luyan Pharma Co (SZSE:002788) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010

Website

http://www.luyan.com.cn

Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.

Executives

Zhu Ming Guo	Executives
Yang Cong Jin	Directors, executives
Lei Ming	Directors, executives
Li Wei Yang	Executives
Cai Mei Zhen	Supervisors
Li Cui Ping	Supervisors
Wu Jin Xiang	Directors, executives
Zhang Jun Ying	Executives
Wu Huo Lu	Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines